1. Luo, Zhuang, Chen, Yong, Chen, Bangquan, Wu, Rongfan, Ren, Jun. 2024. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer. In BMC medical genomics, 17, 82. doi:10.1186/s12920-024-01856-0. https://pubmed.ncbi.nlm.nih.gov/38581025/
2. Zhao, Wenjing, Liang, Ziwei, Yao, Yongshi, Duan, Ling, Yao, Jiannan. 2024. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. In Cancer immunology, immunotherapy : CII, 73, 131. doi:10.1007/s00262-024-03716-3. https://pubmed.ncbi.nlm.nih.gov/38748299/
3. Chen, Wenchao, Yang, Fanfan, Shen, Hao, Xu, Jian, Xu, Bin. 2024. GGT5 as a promising prognostic biomarker and its effects on tumor cell progression in gastric cancer. In Translational cancer research, 13, 4459-4473. doi:10.21037/tcr-23-2222. https://pubmed.ncbi.nlm.nih.gov/39262487/
4. Wei, Jia-Ru, Dong, Jun, Li, Lei. 2020. Cancer-associated fibroblasts-derived gamma-glutamyltransferase 5 promotes tumor growth and drug resistance in lung adenocarcinoma. In Aging, 12, 13220-13233. doi:10.18632/aging.103429. https://pubmed.ncbi.nlm.nih.gov/32640421/
5. Wang, Yuli, Fang, Yuan, Zhao, Fanchen, Fang, Zhihong, Li, Yan. 2022. Identification of GGT5 as a Novel Prognostic Biomarker for Gastric Cancer and its Correlation With Immune Cell Infiltration. In Frontiers in genetics, 13, 810292. doi:10.3389/fgene.2022.810292. https://pubmed.ncbi.nlm.nih.gov/35368661/
智鼠故事 
